![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | A61K 35/74 | (2015.01) |
C12N 1/20 | (2006.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 11/06 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 19/02 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61K 35/745 | (2015.01) |
(11) | Number of the document | 3240554 |
(13) | Kind of document | T |
(96) | European patent application number | 16731640.5 |
Date of filing the European patent application | 2016-06-15 | |
(97) | Date of publication of the European application | 2017-11-08 |
(45) | Date of publication and mention of the grant of the patent | 2019-07-31 |
(46) | Date of publication of the claims translation | 2019-11-11 |
(86) | Number | PCT/GB2016/051770 |
Date | 2016-06-15 |
(87) | Number | WO 2016/203218 |
Date | 2016-12-22 |
(30) | Number | Date | Country code |
201510466 | 2015-06-15 | GB | |
201520508 | 2015-11-20 | GB | |
201606810 | 2016-04-19 | GB |
(72) |
GRANT, George, GB
PATTERSON, Angela Margaret, GB
MULDER, Imke, GB
MCCLUSKEY, Seanin, GB
RAFTIS, Emma, GB
|
(73) |
CJ Bioscience, Inc. ,
7F, B, 14, Sejong-daero, Jung-gu
Seoul 04527,
KR
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Blautia stercosis ir wexlerae, skirtos naudoti uždegiminių ir autoimuninių ligų gydymui |
BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES |
Payment date | Validity (years) | Amount | |
2022-06-15 | 7 | 162.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2023-11-30 |